UK’s ‘resilient’ life sciences sector hopes for upturn after decreases in financing, venture capital in 2023 — report

The UK’s life sci­ences sec­tor took on an­oth­er tough year in 2023, see­ing de­creas­es in both eq­ui­ty fi­nanc­ing and raised ven­ture cap­i­tal, both of which dropped last year from 2022, ac­cord­ing to a new re­port from the UK BioIn­dus­try As­so­ci­a­tion.

But giv­en a “chal­leng­ing glob­al eco­nom­ic cli­mate,” the trade group said the UK’s biotech in­dus­try showed “re­mark­able re­silience and in­vest­ment,” with hopes for re­cov­ery in 2024.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.